Astrid Jullumstrø Feuerherm

Inhibition of Group IVA Cytosolic Phospholipase A₂ by Thiazolyl Ketones in Vitro, ex Vivo, and in Vivo

George Kokotos, Astrid Jullumstrø Feuerherm, Efrosini Barbayianni et al. · Journal of Medicinal Chemistry · 2014 · 40 citations · Full text

Plasma Pge2 Levels, Pharmaceutical Science, Cellular Pharmacology +23

Cytosolic Phospholipase A2 Regulates TNF-Induced Production of Joint Destructive Effectors in Synoviocytes

Randi M. Sommerfelt, Astrid Jullumstrø Feuerherm, Kymry T. Jones et al. · PLoS ONE · 2013 · 39 citations · Full text

Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

Eugene Kim, Hanna Maja Tunset, Jana Cebulla et al. · BMC Cancer · 2016 · 34 citations · Full text

cPLA2α Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation

Felicity Ashcroft, Nur Mahammad, Helene Midtun Flatekvål et al. · Biomolecules · 2020 · 32 citations · Full text

The ω3‐polyunsaturated fatty acid derivatives <scp>AVX</scp>001 and <scp>AVX</scp>002 directly inhibit cytosolic phospholipase <scp>A</scp>₂ and suppress <scp>PGE</scp>₂ formation in mesangial cells

Andrea Huwiler, Astrid Jullumstrø Feuerherm, Benjamin Sakem et al. · British Journal of Pharmacology · 2012 · 29 citations